Stanford University
300 Pasteur Drive, Stanford, CA 94304
USA
Presenters:
Robert Ohgami, MD
Clinical Instructor, Pathology
Stanford University
Alexey Aleshin, MD
Internal Medicine Resident
Stanford University
Ash Alizadeh, MD
Assistant Professor, Oncology
Stanford University
Robert Ohgami: Dr Robert Ohgami received his M.D. and Ph.D. degrees from Harvard Medical School. He completed residency and fellowship training at Stanford University Medical Center and later worked as a post-doctoral fellow with Daniel Arber in the department of pathology at Stanford. Dr. Ohgami is now a clinical instructor in hematopathology and translational researcher at Stanford University who focuses on developing and implementing novel genetic and molecular tools for immediate clinical use.
Alexey Aleshin: Dr. Aleshin is an internal medicine resident at Stanford. He received a BA in Statistics and Molecular and Cell Biology at Berkeley, and he completed his medical degree at UCLA. He also received an MBA at UCLA’s Anderson School of Management.
Ash Alizadeh: The major focus of Dr. Alizadeh’s research group is to attain a better understanding of the initiation, maintenance, and progression of lymphoid tumors, and their response to existing and novel therapies toward improving current treatment strategies. In this effort, they employ tools from functional genomics, computational biology, molecular genetics, and mouse models. They hope to apply this knowledge towards the design of clinical trials in the treatment of patients with lymphoma, leukemia, and myeloma.